https://assets.capyfin.com/instruments/678fdc13234e27009c5d574c.png avatar
Johnson & Johnson
🇺🇸 NYSE:JNJ
View Company
OverviewEarningsDividends
•
Sep 30, 2024

Johnson & Johnson Q3 2024 Earnings Report

Johnson & Johnson reported strong Q3 2024 results, driven by growth in operational sales and pipeline advancements.

Key Takeaways

Johnson & Johnson's Q3 2024 results showed a 5.2% increase in reported sales to $22.5 billion. EPS decreased by 34.3% to $1.11, while adjusted EPS decreased by 9.0% to $2.42. The company has increased its full-year 2024 operational sales guidance and updated its adjusted operational EPS guidance.

Reported sales grew by 5.2% to $22.5 billion.

Operational sales grew by 6.3%.

EPS decreased by 34.3% to $1.11, while adjusted EPS decreased by 9.0% to $2.42.

Full-year 2024 operational sales guidance was increased.

Total Revenue
$22.5B
Previous year: $21.4B
+5.2%
EPS
$2.42
Previous year: $2.66
-9.0%
Gross Profit
$15.5B
Previous year: $14.7B
+5.2%
Cash and Equivalents
$20.3B
Previous year: $19.7B
+2.9%
Free Cash Flow
$6.96B
Previous year: $6.52B
+6.8%
Total Assets
$178B
Previous year: $166B
+7.4%

Johnson & Johnson

Johnson & Johnson

Johnson & Johnson Revenue by Segment

Johnson & Johnson Revenue by Geographic Location

Forward Guidance

Johnson & Johnson updated its 2024 guidance, including adjusted operational EPS guidance, to reflect improved performance and the impact from the recent acquisition of V-Wave.

Positive Outlook

  • Adjusted Operational Sales are expected to be $89.4B – $89.8B.
  • Operational Sales are expected to grow 6.3% – 6.8%.
  • Estimated Reported Sales are expected to be $88.4B – $88.8B.
  • Adjusted Operational EPS (Diluted) are expected to be $9.86 – $9.96.
  • Adjusted EPS (Diluted) are expected to be $9.88 – $9.98.

Challenges Ahead

  • M&A impact (V-Wave) is expected to be a loss of $0.24 in Adjusted Operational EPS.
  • Adjusted Operational EPS (Diluted) are expected to decrease (0.6)% – 0.4%.
  • Adjusted EPS (Diluted) are expected to decrease (0.4)% – 0.6%.
  • Costs associated with the acquisition of V-Wave more than offset the improvement
  • Company does not provide GAAP financial measures on a forward-looking basis because the company is unable to predict with reasonable certainty the ultimate outcome of legal proceedings, unusual gains and losses, acquisition-related expenses, and purchase accounting fair value adjustments without unreasonable effort.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View Johnson & Johnson